Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Respiratory Disease|September 23, 2024
Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatmentHyeontaek Hwang, Joong-Yub Kim, Jae-Joon Yim, et al.
Therapeutic Advances in Respiratory Disease|August 19, 2024
Safety and risk factors for bleeding complications of radial probe endobronchial ultrasound-guided transbronchial biopsyEunhye Bae, Hyeontaek Hwang, Joong-Yub Kim, et al.
Scientific Reports|May 8, 2021
A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemicHyung-Jun Kim, Hyeontaek Hwang, Hyunsook Hong, et al.
Scientific Reports|May 5, 2023
The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysisHyeontaek Hwang, Jung-Kyu Lee, Eun Young Heo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2021
Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or DelamanidHyeontaek Hwang, Hyungseok Kang, Yong-Soo Kwon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2024
Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary DiseaseJoong-Yub Kim, Hyeontaek Hwang, DaHae Yim, et al.
BMJ Open|April 7, 2025
Assessing statistical literacy in medical students and doctors: a single-centre, cross-sectional survey in South KoreaSun Young Lee, Soela Kim, Soyun Kim, et al.
Respiratory Research|April 24, 2020
Validation of age, PaO2/FlO2 and plateau pressure score in Korean patients with acute respiratory distress syndrome: a retrospective cohort studyHyeontaek Hwang, Sun Mi Choi, Jinwoo Lee, et al.
Respiration; International Review of Thoracic Diseases|March 17, 2026
Real-world experience of prolonged treatment for treatment-refractory nontuberculous mycobacterial pulmonary disease: Benefits and harms of extending therapy beyond 24 monthsHyung-Jun Kim, Jieun Kang, Hyeontaek Hwang, et al.
BMC Infectious Diseases|May 9, 2026
Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval processHyeontaek Hwang, Jung Eun Shin, Soonryu Seo, et al.
Pageof 2